Ramji Rajendran, Radiation Oncologist at UroPartners LLC., shared a post on LinkedIn:
“I’m excited to share that I’ve joined The Specialty Alliance, as Medical Director of Theranostics and Radiation Oncologist.
Theranostics is redefining how we deliver cancer care – integrating molecular imaging, targeted radiopharmaceutical therapy, and response assessment into a continuous, patient-centered pathway. What was once emerging is now becoming foundational.
In this new role, I look forward to:
- Expanding access to theranostic therapies throughout the country with The Specialty Alliance.
- Building scalable, high-quality clinical programs
- Integrating imaging and treatment to provide the best value for each dose of therapy delivered.
- Collaborating across disciplines and with industry partners to push the field forward
I’m deeply grateful to my colleagues, mentors, and teams from the past 15 years with Radiation Oncology Consultants – your impact has shaped how I think, lead, and care for patients.
Excited for what’s ahead.”
Other articles on OncoDaily.